Skip to main content
TipRanks
Go Ultimate75% OFF

Advagene Biopharma Co., Ltd. (6709) Balance Sheet

Advagene Biopharma Co., Ltd. Balance Sheet

Advagene Biopharma Co., Ltd.'s total assets for Q2 2026 were NT$366.03M, an increase of 119.82% from the previous quarter. TW:6709 total liabilities were NT$9.60M for the fiscal quarter, a 32.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 166.51MNT$ 232.21MNT$ 147.93MNT$ 140.84MNT$ 260.41M
NT$ 14.26MNT$ 11.67MNT$ 7.97MNT$ 9.08MNT$ 10.84M
NT$ 152.25MNT$ 220.54MNT$ 139.96MNT$ 131.76MNT$ 249.57M

Currency in TWD

Advagene Biopharma Co., Ltd. Liabilities to Assets

0150M300M450M2.5 %5 %7.5 %10 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets